Decitabine Drug Market: Epigenetic Therapy for Hematological Malignancies
Market Overview The Decitabine Drug Market is experiencing steady growth as epigenetic therapies become increasingly important in the treatment of hematological malignancies. Decitabine is a hypomethylating agent approved for the treatment of myelodysplastic syndromes and acute myeloid leukemia, particularly in patients ineligible for intensive chemotherapy. By reactivating silenced...
0 Comments 0 Shares 283 Views 0 Reviews
social art-inpa https://social.art-inpa.com